Published in Oncoimmunology on January 16, 2014
Obesity and Cancer: An Angiogenic and Inflammatory Link. Microcirculation (2016) 0.84
Precision medicine from the renal cancer genome. Nat Rev Nephrol (2016) 0.80
Adipose tissue-secreted miR-27a promotes liver cancer by targeting FOXO1 in obese individuals. Onco Targets Ther (2015) 0.75
Prognostic significance of serum chemerin levels in patients with non-small cell lung cancer. Oncotarget (2017) 0.75
Association of leptin, visfatin, apelin, resistin and adiponectin with clear cell renal cell carcinoma. Oncol Lett (2016) 0.75
IL1 genes polymorphism and the risk of renal cell carcinoma in Chinese Han population. Oncotarget (2017) 0.75
The association between renal sinus fat area and the progression-free survival in Chinese non-metastatic clear-cell renal cell carcinoma patients. Oncotarget (2017) 0.75
Hallmarks of cancer: the next generation. Cell (2011) 140.01
Inflammation and cancer. Nature (2002) 53.78
Targeting HIF-1 for cancer therapy. Nat Rev Cancer (2003) 28.01
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet (2008) 20.62
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med (2002) 8.95
Identification of white adipocyte progenitor cells in vivo. Cell (2008) 6.58
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med (2011) 6.15
Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes (2005) 5.68
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival. Nat Med (2012) 5.44
Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat Rev (2008) 4.25
A key role of leptin in the control of regulatory T cell proliferation. Immunity (2007) 3.71
Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol (2000) 3.67
Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun (2004) 3.21
Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma. J Urol (2010) 2.64
PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer. Cancer Res (2012) 2.43
Lower plasma adiponectin levels are associated with larger tumor size and metastasis in clear-cell carcinoma of the kidney. Eur Urol (2008) 2.42
Inflammation and oncogenesis: a vicious connection. Curr Opin Genet Dev (2009) 2.35
Adiponectin and cancer: a systematic review. Br J Cancer (2006) 2.33
The role of VEGF in the regulation of physiological and pathological angiogenesis. EXS (2005) 1.93
Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J Biol Chem (2005) 1.92
Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma. PLoS One (2012) 1.82
White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models. Cancer Res (2009) 1.78
Human primary adipocytes exhibit immune cell function: adipocytes prime inflammation independent of macrophages. PLoS One (2011) 1.77
Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis. Int J Cancer (2012) 1.61
The growing challenge of obesity and cancer: an inflammatory issue. Ann N Y Acad Sci (2011) 1.47
Leptin promotes differentiation and survival of human dendritic cells and licenses them for Th1 priming. J Immunol (2005) 1.42
Genetically obese MMTV-TGF-alpha/Lep(ob)Lep(ob) female mice do not develop mammary tumors. Breast Cancer Res Treat (2003) 1.39
Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokines. J Leukoc Biol (2002) 1.33
Characteristics and clinical impacts of the immune environments in colorectal and renal cell carcinoma lung metastases: influence of tumor origin. Clin Cancer Res (2013) 1.33
Leptin receptor-deficient MMTV-TGF-alpha/Lepr(db)Lepr(db) female mice do not develop oncogene-induced mammary tumors. Exp Biol Med (Maywood) (2004) 1.31
Leptin inhibits stress-induced apoptosis of T lymphocytes. Clin Exp Immunol (2002) 1.28
The von Hippel-Lindau protein, vascular endothelial growth factor, and kidney cancer. N Engl J Med (2003) 1.23
Visceral fat area as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with antiangiogenic agents. Oncologist (2011) 1.20
Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of Rho kinase/IFN-inducible protein 10/matrix metalloproteinase 9 signaling. Clin Cancer Res (2010) 1.15
Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies. BJU Int (2009) 1.13
Adipose tissue-derived progenitor cells and cancer. World J Stem Cells (2010) 1.12
A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings. Cancer Immunol Immunother (2010) 1.08
Adiponectin is a negative regulator of NK cell cytotoxicity. J Immunol (2006) 1.06
Risk factors for adult renal cell carcinoma. Urol Clin North Am (2004) 1.06
Leptin-cytokine crosstalk in breast cancer. Mol Cell Endocrinol (2013) 1.05
Fatty acid synthase over expression is an indicator of tumor aggressiveness and poor prognosis in renal cell carcinoma. J Urol (2008) 1.03
BMI and the risk of renal cell carcinoma. Curr Opin Urol (2011) 1.03
Transcript signature predicts tissue NK cell content and defines renal cell carcinoma subgroups independent of TNM staging. J Mol Med (Berl) (2011) 1.02
Adiponectin induces dendritic cell activation via PLCγ/JNK/NF-κB pathways, leading to Th1 and Th17 polarization. J Immunol (2012) 1.02
Nox4 mediates renal cell carcinoma cell invasion through hypoxia-induced interleukin 6- and 8- production. PLoS One (2012) 1.01
Renal cell cancer and body size at different ages: an Italian multicenter case-control study. Am J Epidemiol (2007) 1.01
TNF-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a GSK3β-dependent mechanism. Mol Cancer Res (2012) 1.01
Adipocytes Promote B16BL6 Melanoma Cell Invasion and the Epithelial-to-Mesenchymal Transition. Cancer Microenviron (2011) 1.00
Increased serum leptin levels and over expression of leptin receptors are associated with the invasion and progression of renal cell carcinoma. J Urol (2006) 0.99
Leptin promotes cell survival and activates Jurkat T lymphocytes by stimulation of mitogen-activated protein kinase. Clin Exp Immunol (2008) 0.99
Involvement of serum vascular endothelial growth factor family members in the development of obesity in mice and humans. J Nutr Biochem (2009) 0.98
CD158 receptor controls cytotoxic T-lymphocyte susceptibility to tumor-mediated activation-induced cell death by interfering with Fas signaling. Cancer Res (2003) 0.97
Natural killer cell activity and sensitivity to positive and negative modulation in uncomplicated obese subjects: relationships to leptin and diet composition. Int J Obes Relat Metab Disord (2004) 0.97
Adipose tissue immunity and cancer. Front Physiol (2013) 0.96
Resistance of Janus kinase-2 dependent leptin signaling in natural killer (NK) cells: a novel mechanism of NK cell dysfunction in diet-induced obesity. Endocrinology (2008) 0.95
Obesity, adipokines and hepatocellular carcinoma. Int J Cancer (2013) 0.94
Novel immunomodulatory effects of adiponectin on dendritic cell functions. Int Immunopharmacol (2010) 0.94
The role of adiponectin signaling in metabolic syndrome and cancer. Rev Endocr Metab Disord (2014) 0.93
Renal cell carcinoma-infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes. Int J Cancer (2003) 0.93
Leptin-regulated gene expression in MCF-7 breast cancer cells: mechanistic insights into leptin-regulated mammary tumor growth and progression. J Endocrinol (2008) 0.92
Serum leptin and adiponectin levels and risk of renal cell carcinoma. Obesity (Silver Spring) (2013) 0.91
Leptin stimulation of cell cycle and inhibition of apoptosis gene and protein expression in OVCAR-3 ovarian cancer cells. Endocrine (2012) 0.91
The adiponectin signaling pathway as a novel pharmacological target. Mini Rev Med Chem (2006) 0.91
Mutations of the von Hippel-Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma. Oncogene (2011) 0.90
Leptin promotes invasiveness of murine renal cancer cells via extracellular signal-regulated kinases and rho dependent pathway. J Urol (2006) 0.90
Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomas. Blood (2000) 0.89
Structure-function studies of human leptin. J Biol Chem (1998) 0.89
Short-term and long-term leptin exposure differentially affect human natural killer cell immune functions. Am J Physiol Endocrinol Metab (2011) 0.88
Concomitant activation of the JAK/STAT3 and ERK1/2 signaling is involved in leptin-mediated proliferation of renal cell carcinoma Caki-2 cells. Cancer Biol Ther (2008) 0.88
Membrane-bound interleukin (IL)-15 on renal tumor cells rescues natural killer cells from IL-2 starvation-induced apoptosis. Cancer Res (2007) 0.87
Obesity and the associated mediators leptin, estrogen and IGF-I enhance the cell proliferation and early tumorigenesis of breast cancer cells. Nutr Cancer (2009) 0.86
Obesity is associated with an improved cancer-specific survival, but an increased rate of postoperative complications after surgery for renal cell carcinoma. Scand J Urol Nephrol (2012) 0.83
Underactivation of the adiponectin-adiponectin receptor 1 axis in clear cell renal cell carcinoma: implications for progression. Clin Exp Metastasis (2013) 0.83
Analysis of the natural killer mediated immune response in metastatic renal cell carcinoma patients. Int J Cancer (2004) 0.82
Leptin induces tube formation in first-trimester extravillous trophoblast cells. Eur J Obstet Gynecol Reprod Biol (2012) 0.80
Impact of renal vein invasion and fat invasion in pT3a renal cell carcinoma. BJU Int (2011) 0.79
[Leptin: Involvement in the pathophysiology of breast cancer]. Ann Endocrinol (Paris) (2013) 0.77
Expression of p27Kip1, a cell cycle repressor protein, is inversely associated with potential carcinogenic risk in the genetic rodent models of obesity and long-lived Ames dwarf mice. Metabolism (2013) 0.76